Find Reports
Select Report Type
Reimbursement Review
Displaying 1076 - 1100 of 1426
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| Ciprofloxacin hydrochloride an... | Ciprodex | Ciprofloxacin hydrochloride and dexamethasone otic suspension | Otitis media with otorrhea & otitis externa, acute | Do not list | Complete | SR0014-000 | |||
| Butoconazole nitrate | Gynazole.1 | Butoconazole nitrate | Vaginal infection | Do not list | Complete | SR0017-000 | |||
| Dutasteride | Avodart | Dutasteride | Prostatic hyperplasia, benign | List in a similar manner to other drugs in class | Complete | SR0019-000 | |||
| Teriparatide (rDNA origin) inj... | Forteo | Teriparatide (rDNA origin) injection | Osteoporosis | Do not list | Complete | SR0015-000 | |||
| Eprosartan mesylate/ hydrochlo... | Teveten Plus | Eprosartan mesylate/ hydrochlorothiazide | Hypertension, Essential | List in a similar manner to other drugs in class | Complete | SR0016-000 | |||
| Agalsidase alfa | Replagal | Agalsidase alfa | Fabry Disease | Do not list | Complete | SR0006-000 | |||
| Agalsidase beta | Fabrazyme | Agalsidase beta | Fabry Disease | Do not list | Complete | SR0007-000 | |||
| Mixed amphetamine salts | Adderall XR | Mixed amphetamine salts | Attention deficit hyperactivity disorder | Do not list | Complete | SR0010-000 | |||
| Miglustat | Zavesca | Miglustat | Gaucher disease | Do not list | Complete | SR0012-000 | |||
| Treprostinil sodium | Remodulin | Treprostinil sodium | Pulmonary arterial hypertension (NYHA Class III and IV patients) | Do not list | Complete | SR0011-000 | |||
| Pegfilgrastim | Neulasta | Pegfilgrastim | Neutropenia | List with clinical criteria and/or conditions | Complete | SR0009-000 | |||
| Peginterferon alfa-2a and Riba... | Pegasys RBV | Peginterferon alfa-2a and Ribavirin | Hepatitis C, chronic | List in a similar manner to other drugs in class | Complete | SR0013-000 | |||
| Tenofovir disoproxil fumarate | Viread | Tenofovir disoproxil fumarate | HIV infection | Do not list | Complete | SR0008-000 | |||
| Gefitinib | Iressa | Gefitinib | Cancer, Lung , non-small cell | Do not list | Complete | SR0003-000 | |||
| Norgelestromin/ethinyl estradi... | Evra | Norgelestromin/ethinyl estradiol | Contraceptive, patch | Do not list | Complete | SR0004-000 | |||
| Brimonidine tartrate/timolol m... | Combigan Ophthalmic Solution | Brimonidine tartrate/timolol maleate | Glaucoma | List with clinical criteria and/or conditions | Complete | SR0001-000 | |||
| Atazanavir | Reyataz | Atazanavir | HIV infection | List in a similar manner to other drugs in class | Complete | SR0002-000 | |||
| Almotriptan | Axert | Almotriptan | Migraine | List in a similar manner to other drugs in class | Complete | SR0005-000 | |||
| CADTH Pharmaceutical Reviews U... | |||||||||
| osilodrostat | Isturisa | osilodrostat | Endogenous Cushing’s syndrome | Suspended | SR0804-000 | ||||
| risperidone | TBC | risperidone | Schizophrenia, adults | Suspended | SR0811-000 | ||||
| ruxolitinib | Opzelura | ruxolitinib | atopic dermatitis | Active | SR0807-000 | ||||
| letermovir | Prevymis | letermovir | Cytomegalovirus infection (CMV), prophylaxis | Withdrawn | SR0824-000 | ||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| clascoterone | Winlevi | clascoterone | Acne vulgaris | Withdrawn | SR0786-000 |
Health Technology Review
Displaying 601 - 602 of 602
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 1076 - 1100 of 2138
Please scroll or swipe to the right to view the full content.
| Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
|---|---|---|---|---|---|---|---|
| Tuberculosis Stigma and Racism, Colonialism, and Migration: A Rapid Qualitative Review | Health Technology Review | Summary with Critical Appraisal | Completed | RC1350-000 | |||
| Rituximab for the Treatment of Myasthenia Gravis: A 2021 Update | Health Technology Review | Rapid Review | RC1337-000 | ||||
| Urethral Inserts for the Management of Adult Male Urinary Incontinence | Health Technology Review | Rapid Review | Completed | RC1355-000 | |||
| Avelumab (Bavencio) for Urothelial Carcinoma - Details | Reimbursement Review | Complete | PC0225-000 | ||||
| Pharmacological Interventions for Vaping Cessation | Health Technology Review | Summary with Critical Appraisal | Completed | RC1357-000 | |||
| Models of Care for Chronic Pain: An Environmental Scan | Health Technology Review | Environmental Scan | Completed | ES0350-000 | |||
| Bupropion for Treatment Resistant Depression | Health Technology Review | Summary with Critical Appraisal | Completed | RC1351-000 | |||
| Lenses and Spectacles to Prevent Myopia Worsening in Children | Health Technology Review | Summary with Critical Appraisal | RC1349-000 | ||||
| Interferon Gamma Release Assay for the Identification of Latent Tuberculosis Infection in Rural and Remote Settings | Health Technology Review | Summary with Critical Appraisal | Completed | RC1341-000 | |||
| Flash Glucose Monitoring Systems in Pediatric Populations with Diabetes | Health Technology Review | Summary with Critical Appraisal | Completed | RC1354-000 | |||
| Levetiracetam | Reimbursement Review | Complete | SR0653-000 | ||||
| COVID-19 Impact on Intimate Partner Violence and Child Maltreatment | Health Technology Review | CI0145-000 | |||||
| Point-of-Care Testing of International Normalized Ratios for People on Oral Anticoagulants: A Rapid Qualitative Review | Health Technology Review | Summary with Critical Appraisal | Completed | RC1334-000 | |||
| sacubitril/valsartan | Reimbursement Review | Complete | SR0644-000 | ||||
| fremanezumab | Reimbursement Review | Complete | SR0641-000 | ||||
| CADTH Pharmaceutical Reviews Update — Issue 22 | Reimbursement Review | Pharmaceutical Review Update | |||||
| Chronic Lymphocytic Leukemia | Reimbursement Review | Provisional Funding Algorithm | Completed | PH0004-000 | |||
| tafamidis | Reimbursement Review | Complete | SR0625-000 | ||||
| Nivolumab-Ipilimumab for Non-Small Cell Lung Cancer - Details | Reimbursement Review | Complete | PC0218-000 | ||||
| Treatment Sequences of Androgen Receptor Targeted Agents for Patients with Prostate Cancer | Health Technology Review | Summary with Critical Appraisal | Completed | RC1347-000 | |||
| cyclosporine | Reimbursement Review | Complete | SR0615-000 | ||||
| Remote Monitoring Programs for Cardiac Conditions in Canada | Health Technology Review | Environmental Scan | Completed | ES0345-000 | |||
| Interventions to influence the use of antibiotics for acute upper respiratory tract infections | Health Technology Review | Summary with Critical Appraisal | RC1332-000 | ||||
| Onabotulinum Toxin A for Spasticity Associated with Multiple Sclerosis | Health Technology Review | Summary with Critical Appraisal | RC1340-000 | ||||
| Remote Monitoring Programs for Cardiac Conditions in Canada | Health Technology Review | Environmental Scan | ES0345-000 |
Provisional Funding Algorithm
Displaying 76 - 81 of 81